Clinical Trial Update: A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients [Phase 2]

View source ↗

Summary

A Phase 2 multicenter study evaluating four doses of SR147778 for efficacy and safety in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SR147778

Snippet

Sponsor: Sanofi | Conditions: Obesity | Phase 2 | Status: COMPLETED